FGFR3 and breast cancer: While the exact mechanism of how quisinostat inhibits FGFR3 translation is still currently under investigation, nevertheless, our data indicates a new promising strategy of combining FGFR inhibitors with drugs that can inhibit FGFR expression or facilitate FGFR degradation to enhance the efficiency and prevent/overcome drug resistance for BC treatment.